Lange A P, Secher N J, Amery W
Acta Med Scand. 1977;202(6):449-54. doi: 10.1111/j.0954-6820.1977.tb16863.x.
Loperamide was compared double-blind with diphenoxylate and a placebo in 59 women with diarrhoea due to prostaglandin administration for mid-trimester abortion. Treatment was started with the intake of two capsules two hours before the first intramuscular injection of 15(S-)15 methyl prostaglandin F2alpha and was then adapted individually, i.e. one capsule after each unformed stool, with a maximum of ten per 24 hours. Both antidiarrhoeals were significantly more effective than the placebo in preventing diarrhoea, and loperamide was found to be more active than diphenoxylate. The course of abortion, BP and vital signs, or prostaglandin side-effects other than diarrhoea were not affected by either antidiarrhoeal, nor could any adverse experience be specifically attributed to them.
在59名因孕中期堕胎使用前列腺素而腹泻的女性中,将洛哌丁胺与地芬诺酯及安慰剂进行了双盲对照试验。治疗在首次肌内注射15(S)-15甲基前列腺素F2α前两小时开始,服用两粒胶囊,然后根据个体情况调整,即每次不成形大便后服用一粒胶囊,每24小时最多服用十粒。两种止泻药在预防腹泻方面均显著优于安慰剂,且发现洛哌丁胺比地芬诺酯更有效。两种止泻药均未影响堕胎过程、血压和生命体征,也未影响除腹泻以外的前列腺素副作用,也未发现任何不良事件可明确归因于它们。